Martin Johnson

8.0k total citations · 1 hit paper
136 papers, 5.0k citations indexed

About

Martin Johnson is a scholar working on Plant Science, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Martin Johnson has authored 136 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Plant Science, 51 papers in Pulmonary and Respiratory Medicine and 33 papers in Pharmacology. Recurrent topics in Martin Johnson's work include Pesticide Exposure and Toxicity (53 papers), Pulmonary Hypertension Research and Treatments (45 papers) and Cholinesterase and Neurodegenerative Diseases (31 papers). Martin Johnson is often cited by papers focused on Pesticide Exposure and Toxicity (53 papers), Pulmonary Hypertension Research and Treatments (45 papers) and Cholinesterase and Neurodegenerative Diseases (31 papers). Martin Johnson collaborates with scholars based in United Kingdom, United States and Spain. Martin Johnson's co-authors include Marcello Lotti, Andrew J. Peacock, Bruce Clothier, D. J. Read, W. N. Aldridge, Joanna Pepke‐Żaba, Gerry Coghlan, David G. Kiely, Paul A. Corris and Charlie Elliot and has published in prestigious journals such as Nature, New England Journal of Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Martin Johnson

134 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Changing Demographics, Epidemiology, and Survival of Incident Pulmonary Arterial Hypertension: Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland

2012 392 citations Yi Ling, Martin Johnson et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers

Countries citing papers authored by Martin Johnson

Since Specialization

Citations

This map shows the geographic impact of Martin Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Johnson more than expected).

Fields of papers citing papers by Martin Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Johnson. The network helps show where Martin Johnson may publish in the future.

Co-authorship network of co-authors of Martin Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Johnson. A scholar is included among the top collaborators of Martin Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Johnson. Martin Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sendaway capillary NT-proBNP in pulmonary hypertension 2024 ·BMJ Open Respiratory Research ·Harrison Stubbs, John Cannon, (unknown), (unknown), Chloe Roddis, Wendy Gin‐Sing, (unknown), Daniel Knight, (unknown), James Lordan, (unknown), (unknown), Eleanor Morris, Martin Johnson, Stephen J. Wort	2
2	Pulmonary Embolism (PE) to Chronic Thromboembolic Pulmonary Disease (CTEPD): Findings from a Survey of UK Physicians 2024 ·Advances in respiratory medicine ·Joanna Pepke‐Żaba, Luke Howard, David G. Kiely, (unknown), Martin Johnson	0
3	The MRC Dyspnoea Scale and mortality risk prediction in pulmonary arterial hypertension: A retrospective longitudinal cohort study 2023 ·Pulmonary Circulation ·(unknown), Bhautesh Jani, Colin Church, Melanie Brewis, Martin Johnson, Harrison Stubbs	1
4	Remote exercise testing in pulmonary hypertension (PHRET) 2023 ·Pulmonary Circulation ·Harrison Stubbs, (unknown), (unknown), Bhautesh Jani, Melanie Brewis, Colin Church, Martin Johnson	6
5	Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study 2023 ·European Heart Journal ·(unknown), Luke Howard, Martin Johnson, David G. Kiely, James Lordan, Colm McCabe, Joanna Pepke‐Żaba, Rose Ong, Michael Preiß, Daniel Knight, Vivek Muthurangu, Gerry Coghlan	20
6	Towards telemedicine in pulmonary hypertension: Assessing the feasibility of remote quality of life and exercise capacity assessment 2022 ·Pulmonary Circulation ·Harrison Stubbs, Melanie Brewis, Colin Church, Martin Johnson	4
7	Predicting Group II pulmonary hypertension: diagnostic accuracy of the H2FPEF and OPTICS scores in Scotland 2022 ·Open Heart ·Harrison Stubbs, (unknown), Michael McGettrick, Bhautesh Jani, Melanie Brewis, Colin Church, Martin Johnson	4
8	Impairment of skeletal muscle oxygen extraction and cardiac output are matched in precapillary pulmonary hypertension 2021 ·ERJ Open Research ·Harrison Stubbs, Colin Church, Martin Johnson, (unknown)	2
9	Apoptosis signal‐regulating kinase 1 inhibition in in vivo and in vitro models of pulmonary hypertension 2020 ·Pulmonary Circulation ·K. Wilson, (unknown), Kornelija Suveizdytė, John T. Liles, Grant R. Budas, (unknown), Margaret R. MacLean, Martin Johnson, Colin Church, Andrew J. Peacock, David Welsh	5
10	Severe pulmonary hypertension in lung disease: phenotypes and response to treatment 2015 ·European Respiratory Journal ·Melanie Brewis, Colin Church, Martin Johnson, Andrew J. Peacock	48
11	The prevalence of ventilatory limitation at peak exercise in pulmonary arterial hypertension 2014 ·European Respiratory Journal ·(unknown), (unknown), Martin Johnson	1
12	Is systemic oxygen extraction on exercise impaired in pulmonary arterial hypertension? 2013 ·European Respiratory Journal ·(unknown), Martin Johnson	2
13	Changing Demographics, Epidemiology, and Survival of Incident Pulmonary Arterial Hypertension: Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland breakdown → 2012 ·American Journal of Respiratory and Critical Care Medicine ·Yi Ling, Martin Johnson, David G. Kiely, Robin Condliffe, Charlie Elliot, J. Simon R. Gibbs, Luke Howard, Joanna Pepke‐Żaba, Karen Sheares, Paul A. Corris, Andrew J. Fisher, James Lordan, Seán Gaine, Gerry Coghlan, SJ Wort, Michael Α. Gatzoulis, Andrew J. Peacock	392
14	Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era 2008 ·American Journal of Respiratory and Critical Care Medicine ·Robin Condliffe, David G. Kiely, Andrew J. Peacock, Paul A. Corris, J. Simon R. Gibbs, (unknown), Clare Das, Charlie Elliot, Martin Johnson, (unknown), (unknown), Kimberley Goldsmith, (unknown), Rodney Hughes, Joanna Pepke‐Żaba, Gerry Coghlan	452
15	Use of reactance to estimate transpulmonary resistance 2005 ·European Respiratory Journal ·Martin Johnson, Malcolm Birch, R. Carter, John Kinsella, Robin Stevenson	20
16	Hospital at home services for acute exacerbation of chronic obstructive pulmonary disease: a survey of British practice. 2001 ·PubMed ·Martin Johnson, (unknown), Jonathan Fuld, Adam Irwin, Cynthia M. Stewart, Robin Stevenson	15
17	Reactivation of phosphorodiamidated acetylcholinesterase and neuropathy target esterase by treatment of inhibited enzyme with potassium fluoride 1993 ·Chemico-Biological Interactions ·Dejan Milatović, Martin Johnson	19
18	Hydrolysis of some organophosphorus dichlorophenyl esters by hen brain homogenates and rabbit serum compared with hydrolysis of paraoxon 1993 ·Chemico-Biological Interactions ·Elsa Reiner, Martin Johnson, Milan Jokanović	9
19	Purification of Neuropathy Target Esterase from Avian Brain After Prelabelling with [³H]Diisopropyl Phosphorofluoridate 1992 ·Journal of Neurochemistry ·(unknown), D. J. Read, Martin Johnson	16
20	Degradation by rat tissues in vitro of organophosphorus esters which inhibit cholinesterase 1989 ·Biochemical Pharmacology ·Antonio Pla, Martin Johnson	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact